|
CA2550361C
(en)
|
2003-12-19 |
2014-04-29 |
Prabha Ibrahim |
Compounds and methods for development of ret modulators
|
|
JP4834840B2
(ja)
|
2004-01-06 |
2011-12-14 |
ノヴォ ノルディスク アー／エス |
ヘテロアリール尿素およびグルコキナーゼ活性化剤としてのその使用
|
|
US20080293716A1
(en)
*
|
2004-01-30 |
2008-11-27 |
Smithkline Beecham Corporation |
Chemical Compounds
|
|
TWI372624B
(en)
*
|
2004-03-30 |
2012-09-21 |
Vertex Pharma |
Azaindoles useful as inhibitors of jak and other protein kinases
|
|
US7498342B2
(en)
|
2004-06-17 |
2009-03-03 |
Plexxikon, Inc. |
Compounds modulating c-kit activity
|
|
MXPA06014415A
(es)
*
|
2004-06-24 |
2007-02-19 |
Shionogi & Co |
Compuestos de sulfonamida.
|
|
WO2006004984A1
(en)
*
|
2004-06-30 |
2006-01-12 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of protein kinases
|
|
MX2007000092A
(es)
*
|
2004-06-30 |
2007-03-07 |
Vertex Pharma |
Azaindoles utiles como inhibidores de proteinas cinasas.
|
|
SG155222A1
(en)
*
|
2004-08-13 |
2009-09-30 |
Genentech Inc |
Thiazole based inhibitors of atp-utilizing enzymes
|
|
EP1814883A1
(en)
*
|
2004-11-22 |
2007-08-08 |
Vertex Pharmaceuticals Incorporated |
Bicyclic inhibitors or rho kinase
|
|
US20090264650A1
(en)
*
|
2005-03-31 |
2009-10-22 |
Nobuo Cho |
Prophylactic/Therapeutic Agent for Diabetes
|
|
WO2006127587A1
(en)
*
|
2005-05-20 |
2006-11-30 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyridines useful as inhibitors of protein kinase
|
|
US7582769B2
(en)
|
2005-07-08 |
2009-09-01 |
Novo Nordisk A/S |
Dicycloalkyl urea glucokinase activators
|
|
US7884210B2
(en)
*
|
2005-07-14 |
2011-02-08 |
Novo Nordisk A/S |
Ureido-thiazole glucokinase activators
|
|
US8211919B2
(en)
|
2005-09-02 |
2012-07-03 |
Astellas Pharma Inc. |
Amide derivatives as rock inhibitors
|
|
US7592461B2
(en)
|
2005-12-21 |
2009-09-22 |
Bristol-Myers Squibb Company |
Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
|
WO2007076423A2
(en)
*
|
2005-12-22 |
2007-07-05 |
Smithkline Beecham Corporation |
INHIBITORS OF Akt ACTIVITY
|
|
CN102532133A
(zh)
|
2006-01-17 |
2012-07-04 |
沃泰克斯药物股份有限公司 |
适用作詹纳斯激酶抑制剂的吖吲哚类
|
|
BRPI0710479A2
(pt)
*
|
2006-01-18 |
2012-08-14 |
Hoffmann La Roche |
composto, processo para sua preparaÇço, composiÇço farmacÊutica, uso de um composto e mÉtodo de tratamento de doenÇa ou desosrdem metabàlica.
|
|
AU2007208358A1
(en)
*
|
2006-01-23 |
2007-08-02 |
Vertex Pharmaceuticals Incorporated |
Thiophene-carboxamides useful as inhibitors of protein kinases
|
|
NZ570103A
(en)
*
|
2006-01-26 |
2011-11-25 |
Foldrx Pharmaceuticals Inc |
Compounds and methods for modulating protein trafficking
|
|
JP2009532475A
(ja)
*
|
2006-04-05 |
2009-09-10 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ヤヌスキナーゼの阻害剤として有用なデアザプリン
|
|
EP2418210A1
(en)
|
2006-04-13 |
2012-02-15 |
Vertex Pharmceuticals Incorporated |
Thiophene-carboxamides useful as inhibitors of protein kinases
|
|
JP2009538309A
(ja)
|
2006-05-23 |
2009-11-05 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なチオフェンカルボキサミド
|
|
AU2007268056A1
(en)
|
2006-05-23 |
2007-12-06 |
Vertex Pharmaceuticals Incorporated |
Thiophene-carboxamides useful as inhibitors of protein kinases
|
|
FR2907120B1
(fr)
|
2006-10-12 |
2013-01-11 |
Sanofi Aventis |
Nouveaux derives imidazolones,leur preparation a titre de medicaments,compositions pharmaceutiques,utilisation comme inhibiteurs de proteines kinases notamment cdc7
|
|
WO2008063888A2
(en)
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
|
WO2008079909A1
(en)
*
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
|
AU2007338754A1
(en)
|
2006-12-21 |
2008-07-03 |
Vertex Pharmaceuticals Incorporated |
5-cyan0-4- (pyrrolo [2, 3B] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
|
|
WO2008084044A1
(en)
|
2007-01-11 |
2008-07-17 |
Novo Nordisk A/S |
Urea glucokinase activators
|
|
GB0702259D0
(en)
*
|
2007-02-06 |
2007-03-14 |
Eisai London Res Lab Ltd |
7-azaindole derivatives
|
|
WO2008112297A2
(en)
*
|
2007-03-13 |
2008-09-18 |
Yale University |
Methods of treating cancer by interfering with igf-i receptor signaling
|
|
JP2010533729A
(ja)
|
2007-07-17 |
2010-10-28 |
プレキシコン，インコーポレーテッド |
キナーゼ調節のための化合物と方法、及びそのための適応
|
|
KR20210070407A
(ko)
|
2007-08-29 |
2021-06-14 |
센주 세이야꾸 가부시키가이샤 |
각막 내피 세포 접착 촉진제
|
|
AR071717A1
(es)
|
2008-05-13 |
2010-07-07 |
Array Biopharma Inc |
Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer.
|
|
EP2303852A4
(en)
*
|
2008-06-26 |
2011-12-28 |
Glaxosmithkline Llc |
ACTIVITY INHIBITORS AKT
|
|
JP2011525930A
(ja)
*
|
2008-06-26 |
2011-09-29 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
Ａｋｔ活性の阻害剤
|
|
GB0812648D0
(en)
*
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
|
EP2559455A1
(en)
|
2008-07-15 |
2013-02-20 |
Novartis AG |
Heteroaryl derivatives as DGAT1 inhibitors
|
|
CN102159574A
(zh)
*
|
2008-07-23 |
2011-08-17 |
沃泰克斯药物股份有限公司 |
三-环吡唑并吡啶激酶抑制剂
|
|
AU2009274023A1
(en)
|
2008-07-23 |
2010-01-28 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
|
MX2011000834A
(es)
*
|
2008-07-23 |
2011-04-05 |
Vertex Pharma |
Inhibidores de pirazolopiridin cinasa.
|
|
ES2402087T3
(es)
|
2008-07-23 |
2013-04-26 |
Vertex Pharmaceuticals Incorporated |
Inhibidores de la pirazolopiridina quinasa
|
|
DE102008038221A1
(de)
|
2008-08-18 |
2010-02-25 |
Merck Patent Gmbh |
7-Azaindolderivate
|
|
EP2403860B1
(en)
*
|
2009-03-04 |
2015-11-04 |
IDENIX Pharmaceuticals, Inc. |
Phosphothiophene and phosphothiazole as hcv polymerase inhibitors
|
|
KR101739994B1
(ko)
|
2009-04-03 |
2017-05-25 |
에프. 호프만-라 로슈 아게 |
프로판-１-술폰산 ｛３-［５-（４-클로로-페닐）-１Ｈ-피롤로［２，３-ｂ］피리딘-３-카르보닐］-２，４-디플루오로-페닐｝-아미드 조성물 및 그의 용도
|
|
CA2760705A1
(en)
|
2009-05-06 |
2010-11-11 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridines
|
|
RS57869B1
(sr)
|
2009-06-17 |
2018-12-31 |
Vertex Pharma |
Inhibitori replikacije virusa gripa
|
|
US8329724B2
(en)
|
2009-08-03 |
2012-12-11 |
Hoffmann-La Roche Inc. |
Process for the manufacture of pharmaceutically active compounds
|
|
CN102066372B
(zh)
|
2009-08-24 |
2014-09-17 |
苏州爱斯鹏药物研发有限责任公司 |
含脲基的5，6元杂芳双环化合物作为激酶抑制剂
|
|
NZ599866A
(en)
|
2009-11-06 |
2014-09-26 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
DE102009058280A1
(de)
|
2009-12-14 |
2011-06-16 |
Merck Patent Gmbh |
Thiazolderivate
|
|
MX2012008643A
(es)
|
2010-01-27 |
2013-02-26 |
Vertex Pharma |
Inhibidores de cinasas de pirazolopiridinas.
|
|
WO2011094288A1
(en)
|
2010-01-27 |
2011-08-04 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyrazine kinase inhibitors
|
|
EP2528917B1
(en)
|
2010-01-27 |
2016-10-19 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridines useful for the treatment of autoimmune, inflammatory or (hyper)proliferative diseases
|
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
|
US9133123B2
(en)
|
2010-04-23 |
2015-09-15 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
US8877794B2
(en)
*
|
2010-08-13 |
2014-11-04 |
Abbott Laboratories |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
AU2011343642A1
(en)
|
2010-12-16 |
2013-05-02 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
|
KR101911972B1
(ko)
|
2011-02-07 |
2018-10-25 |
플렉시콘 인코퍼레이티드 |
키나제 조절을 위한 화합물 및 방법, 및 그에 대한 적응증
|
|
TWI558702B
(zh)
|
2011-02-21 |
2016-11-21 |
普雷辛肯公司 |
醫藥活性物質的固態形式
|
|
US8759380B2
(en)
|
2011-04-22 |
2014-06-24 |
Cytokinetics, Inc. |
Certain heterocycles, compositions thereof, and methods for their use
|
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
|
DE102011083283A1
(de)
*
|
2011-09-23 |
2013-03-28 |
Beiersdorf Ag |
Heteroalkylamidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Heteroalkylamidothiazolen
|
|
LT2788472T
(lt)
|
2011-12-06 |
2019-04-10 |
Astellas Institute For Regenerative Medicine |
Kryptingos diferenciacijos būdas, skirtas ragenos endotelio ląstelių gamybai
|
|
EP2799537B1
(en)
|
2011-12-28 |
2021-09-22 |
Kyoto Prefectural Public University Corporation |
Normalization of culture of corneal endothelial cells
|
|
CN107007597A
(zh)
|
2012-05-31 |
2017-08-04 |
菲尼克斯药品股份公司 |
作为孤儿核受体RORγ调节物的经甲酰胺或磺酰胺取代的噻唑及相关衍生物的制药用途
|
|
US9150570B2
(en)
|
2012-05-31 |
2015-10-06 |
Plexxikon Inc. |
Synthesis of heterocyclic compounds
|
|
WO2014001973A1
(en)
|
2012-06-29 |
2014-01-03 |
Pfizer Inc. |
NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-d]PYRIMIDINES AS LRRK2 INHIBITORS
|
|
WO2014177699A1
(en)
*
|
2013-05-03 |
2014-11-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Rhoa (rock) inhibitors for the treatment of enflammatory bowel disease
|
|
US10908161B2
(en)
|
2013-07-30 |
2021-02-02 |
Kyoto Prefectural Public University Corporation |
Corneal endothelial cell marker
|
|
CA2927898C
(en)
|
2013-10-31 |
2021-11-16 |
Kyoto Prefectural Public University Corporation |
Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endothelium
|
|
HRP20181272T1
(hr)
|
2013-11-13 |
2018-10-05 |
Vertex Pharmaceuticals Incorporated |
Postupci priprave inhibitora replikacije virusa influence
|
|
RS59144B1
(sr)
|
2013-11-13 |
2019-09-30 |
Vertex Pharma |
Inhibitori replikacije virusa influence
|
|
BR112016011096A2
(pt)
|
2013-11-27 |
2017-09-19 |
Kyoto Prefectural Public Univ Corp |
Aplicação de laminina à cultura de célula endotelial da córnea
|
|
JP6487921B2
(ja)
|
2013-12-17 |
2019-03-20 |
ファイザー・インク |
ＬＲＲＫ２阻害薬としての新規の３，４−二置換−１Ｈ−ピロロ［２，３−ｂ］ピリジンおよび４，５−二置換−７Ｈ−ピロロ［２，３−ｃ］ピリダジン
|
|
TR201820925T4
(tr)
|
2014-02-04 |
2019-01-21 |
Taiho Pharmaceutical Co Ltd |
Azaindol türevi.
|
|
WO2016026078A1
(en)
*
|
2014-08-19 |
2016-02-25 |
Changzhou Jiekai Pharmatech Co., Ltd. |
Heterocyclic compounds as erk inhibitors
|
|
CA2960277A1
(en)
*
|
2014-09-10 |
2016-03-17 |
Epizyme, Inc. |
Substituted pyrrolidine carboxamide compounds
|
|
JP6857617B2
(ja)
|
2015-05-13 |
2021-04-14 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
インフルエンザウイルスの複製の阻害剤
|
|
JP6704416B2
(ja)
|
2015-05-13 |
2020-06-03 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
インフルエンザウイルスの複製の阻害剤を調製する方法
|
|
KR102161364B1
(ko)
|
2015-09-14 |
2020-09-29 |
화이자 인코포레이티드 |
LRRK2 억제제로서 이미다조[4,5-c]퀴놀린 및 이미다조[4,5-c][1,5]나프티리딘 유도체
|
|
WO2017064119A1
(en)
|
2015-10-13 |
2017-04-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion
|
|
EP4088719A1
(en)
|
2015-10-13 |
2022-11-16 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion
|
|
PL3416658T3
(pl)
|
2016-02-15 |
2023-09-04 |
Kyoto Prefectural Public University Corporation |
Funkcjonalna ludzka komórka śródbłonka rogówki i jej zastosowanie
|
|
CN108203433B
(zh)
*
|
2016-12-16 |
2020-07-03 |
成都先导药物开发股份有限公司 |
一种rock抑制剂及其应用
|
|
CN108948002A
(zh)
|
2017-05-19 |
2018-12-07 |
厦门大学 |
五元并六元氮杂芳环类化合物、其制备方法、药用组合物及其应用
|
|
ES2841951T3
(es)
*
|
2018-04-17 |
2021-07-12 |
Univ Masarykova |
Propanamidas sustituidas como inhibidores de nucleasas
|
|
CN112040945A
(zh)
|
2018-06-12 |
2020-12-04 |
Vtv治疗有限责任公司 |
葡萄糖激酶激活剂与胰岛素或胰岛素类似物组合的治疗用途
|
|
US20210207088A1
(en)
|
2018-08-31 |
2021-07-08 |
The Doshisha |
Composition and method for preserving or culturing ocular cells
|
|
CN113015429A
(zh)
|
2018-10-02 |
2021-06-22 |
学校法人同志社 |
用于保存角膜内皮细胞的方法和容器
|
|
MX2021005171A
(es)
*
|
2018-11-16 |
2021-10-01 |
California Inst Of Techn |
Inhibidores de cinasas reguladas por señal extracelular (erk) y usos de los mismos.
|
|
TW202043205A
(zh)
|
2018-12-31 |
2020-12-01 |
美商拜歐米富士恩有限公司 |
Menin-mll相互作用之抑制劑
|
|
EP3906026A4
(en)
|
2018-12-31 |
2022-10-19 |
Biomea Fusion, LLC |
IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION
|
|
WO2021064141A1
(en)
*
|
2019-10-02 |
2021-04-08 |
Tolremo Therapeutics Ag |
Inhibitors of dual specificity tyrosine phosphorylation regulated kinase 1b
|
|
US12391658B2
(en)
|
2020-02-18 |
2025-08-19 |
Vtv Therapeutics Llc |
Sulfoxide and sulfone glucokinase activators and methods of use thereof
|
|
KR20220146552A
(ko)
|
2020-02-27 |
2022-11-01 |
교토후고리츠다이가쿠호진 |
인간 기능성 각막 내피 세포 및 그 응용
|
|
CA3181722A1
(en)
|
2020-06-08 |
2021-12-16 |
Jing TENG |
Salts or co-crystals of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof
|
|
CA3179059A1
(en)
*
|
2020-06-09 |
2021-12-16 |
Anima Biotech Inc. |
Collagen 1 translation inhibitors and methods of use thereof
|
|
CA3196110A1
(en)
|
2020-10-22 |
2022-04-28 |
Shigeru Kinoshita |
A storage method of human corneal endothelial cells and/or human corneal endothelial precursor cells
|
|
US20240368541A1
(en)
|
2021-05-03 |
2024-11-07 |
Astellas Institute For Regenerative Medicine |
Methods of generating mature corneal endothelial cells
|
|
AU2022325861A1
(en)
|
2021-08-11 |
2024-02-29 |
Biomea Fusion, Inc. |
Covalent inhibitors of menin-mll interaction for diabetes mellitus
|
|
IL310717A
(en)
|
2021-08-20 |
2024-04-01 |
Biomea Fusion Inc |
Crystalline form of N-[4-[4-(4-morpholinyl)-7H-PYRROLO[2,3-D]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO ] -2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINECARBOXAMIDE, IRREVERSIBLE MENIN-MLL INHIBITOR FOR CANCER TREATMENT
|
|
EP4431596A4
(en)
|
2021-11-11 |
2026-01-14 |
The Doshisha |
CRYOCONSERVATION PREPARATION FOR CORNIAL ENDOTHELIAL CELLS AND PROCESS FOR PRODUCING SAID CRYOCONSERVATION PREPARATION
|
|
WO2024155710A1
(en)
|
2023-01-18 |
2024-07-25 |
Biomea Fusion, Inc. |
Crystalline forms of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6- yl]phenyl]-4-[[3(r)-[(l-oxo-2-propen-l-yl)amino]-l-piperidinyl]methyl]-2-pyridinecarboxamide as a covalent inhibitor of menin-mll interaction
|
|
CN116768881B
(zh)
*
|
2023-06-30 |
2025-09-09 |
郑州大学 |
4-(3-吲哚基)-1,3-噻唑类化合物及其制备方法和应用
|
|
WO2025224050A1
(en)
|
2024-04-22 |
2025-10-30 |
Institut National de la Santé et de la Recherche Médicale |
Methods of treatment of patients suffering from hypomelanosis of ito
|